YOLFTbeta
Zhejiang DiAn Diagnostics Co

Zhejiang DiAn Diagnostics Co

300244 · SHE · Healthcare / Diagnostics & Research

20.07CNY-1.11 (-5.24%)

Price History

Full chart

Market Stats

Previous Close21.18
Open21.26
Day Range19.92 – 21.34
52-Week Range14.22 – 32.69
Volume44.69M
Market Cap12.82B
P/E (TTM)46.64
Forward P/E17.27
EPS0.44
Dividend Yield1.71%
Beta0.70
50-Day Avg18.92
200-Day Avg19.90

About

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series. In addition, the company offers diagnostic product supply, medical testing services, supply chain optimization, digital operation management, laboratory quality system construction, and professional cold chain logistics services. Further, it is involved in the research and development of diagnostic products; and vitro diagnostic reagents, as well as forensic identification, health management, and other fields. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Haibin Chen B.S. (EMBA)
  • Employees7.46K
  • HeadquartersBuilding 2, Hangzhou, China, 310030, China
  • Websitehttps://www.dazd.cn

Leadership

  • Mr. Haibin Chen B.S. (EMBA)GM & Chairman of the Board · b. 1969
  • Mr. Dekang ZhaoDeputy GM, Head of Accounting Agency, Financial Manager & Director · b. 1968
  • Mr. Sanhui GuoDeputy General Manager & Director · b. 1975
  • Mr. Weiyan WuDeputy General Manager · b. 1971
  • Ms. Jun TaoDeputy GM & Secretary of the Board · b. 1981

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue178.29M263.25M343.27M482.47M706.42M1.02B1.34B1.86B3.82B5.00B6.97B8.45B10.65B13.08B20.28B13.41B12.20B10.10B
Growth (%)-+47.65%+30.40%+40.55%+46.42%+43.75%+31.48%+39.18%+105.79%+30.86%+39.22%+21.33%+25.98%+22.85%+55.03%-33.89%-9.04%-17.22%
Cost of Revenue125.69M170.17M220.30M314.21M454.14M638.65M847.78M1.23B2.62B3.34B4.61B5.75B6.60B8.10B12.81B9.26B8.81B7.22B
Gross Profit52.60M93.09M122.97M168.26M252.28M376.82M487.32M624.72M1.20B1.66B2.36B2.70B4.05B4.98B7.47B4.15B3.38B2.87B
Gross Margin29.51%35.36%35.82%34.88%35.71%37.11%36.50%33.62%31.36%33.26%33.90%31.99%38.06%38.09%36.85%30.97%27.75%28.47%
Operating Expense42.77M71.13M88.15M125.91M186.04M268.59M337.10M430.18M783.74M1.07B1.64B1.93B2.73B3.14B4.65B3.31B3.42B2.13B
Operating Income9.84M21.95M34.82M42.36M66.24M108.23M150.22M194.54M415.50M592.90M721.40M774.57M1.32B1.84B2.82B842.18M-31.12M741.48M
Operating Margin5.52%8.34%10.14%8.78%9.38%10.66%11.25%10.47%10.87%11.85%10.35%9.16%12.40%14.05%13.92%6.28%-0.26%7.34%
EBITDA13.31M28.35M45.84M58.45M78.63M126.78M171.80M229.68M471.99M655.61M1.07B1.26B2.20B2.47B4.25B1.47B928.27M874.07M
EBITDA Margin7.47%10.77%13.35%12.11%11.13%12.49%12.87%12.36%12.34%13.10%15.36%14.91%20.61%18.87%20.94%10.94%7.61%8.66%
Net Income6.59M17.17M32.41M42.21M60.19M86.09M124.58M174.79M262.76M349.59M388.61M347.28M802.93M1.16B1.43B307.46M-357.28M44.05M
Net Income Margin3.70%6.52%9.44%8.75%8.52%8.48%9.33%9.41%6.87%6.99%5.58%4.11%7.54%8.89%7.07%2.29%-2.93%0.44%
R&D---10.66M22.55M33.35M57.04M78.18M101.16M131.96M166.27M212.50M319.10M424.75M638.47M432.64M309.18M254.54M
R&D as % of Total Revenue---2.21%3.19%3.28%4.27%4.21%2.65%2.64%2.39%2.51%3.00%3.25%3.15%3.23%2.54%2.52%
Interest Expense2.86M2.86M1.34M471.62K2.19M2.49M1.13M21.93M37.92M113.75M172.19M224.03M217.94M237.28M293.95M250.60M221.68M161.46M
Interest Expense % of Total Revenue1.60%1.09%0.39%0.10%0.31%0.25%0.08%1.18%0.99%2.27%2.47%2.65%2.05%1.81%1.45%1.87%1.82%1.60%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets110.82M178.69M234.25M600.69M706.15M811.49M1.11B2.29B5.72B7.39B10.67B10.75B12.40B15.59B21.06B17.94B15.79B14.42B
Total Liabilities82.96M68.37M74.33M123.66M178.83M221.68M406.86M1.23B3.17B4.44B5.96B5.61B6.37B8.12B11.55B8.03B7.02B5.82B
Total Equity24.27M105.41M151.69M464.27M509.13M576.66M683.89M926.88M2.09B2.35B3.68B3.98B4.70B5.84B7.45B7.57B6.56B6.44B
Cash13.76M58.58M84.00M340.84M277.72M272.10M308.51M230.35M539.39M755.38M1.71B1.31B1.74B2.19B4.20B2.97B1.83B2.11B
Total Debt41.35M31.00M15.00M59.83K900.00K30.00M130.91M650.41M1.75B3.13B3.61B3.37B3.76B4.37B6.02B3.55B2.40B-
Net Debt27.59M-27.58M-69.00M-340.78M-276.82M-242.10M-177.60M420.06M1.21B2.38B1.90B2.07B2.01B2.18B1.82B576.84M571.47M-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.67M4.06M41.23M20.20M25.66M75.44M117.95M131.29M132.25M38.51M373.24M483.19M1.55B1.32B1.64B1.92B1.21B2.03B
Investing Cash Flow-14.41M-12.35M-17.01M-204.17M107.14M-60.48M-128.72M-724.89M-1.85B-1.12B-495.49M-241.31M-820.74M-536.22M-1.07B-625.67M-535.24M-
Financing Cash Flow18.26M53.58M1.66M252.96M-7.92M-20.58M46.25M514.81M2.03B1.29B1.02B-676.29M-256.37M-309.99M1.43B-2.50B-1.83B-
Capital Expenditure12.11M12.88M17.95M23.31M42.98M47.60M125.44M154.88M317.46M382.04M456.68M411.50M475.71M589.50M947.72M701.77M363.19M285.32M
Free Cash Flow-15.78M-8.82M23.28M-3.10M-17.32M27.84M-7.49M-23.59M-185.21M-343.53M-83.44M71.69M1.07B728.42M691.64M1.22B844.20M1.74B
Dividends Paid2.74M2.91M1.35M511.84K17.52M11.66M24.64M39.53M58.77M89.17M174.64M15.51M79.42M80.66M83.76M300.62M575.71M255.80M
FCF to OCF429.82%-217.48%56.46%-15.36%-67.51%36.91%-6.35%-17.97%-140.05%-892.03%-22.36%14.84%69.25%55.27%42.19%63.48%69.92%85.93%
Dividend Paid to FCF-17.35%-32.97%5.81%-16.49%-101.17%41.87%-328.87%-167.52%-31.73%-25.96%-209.30%21.64%7.41%11.07%12.11%24.65%68.20%14.68%

Earnings

Report DateSep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 26, 2014Oct 22, 2014Feb 28, 2015Apr 26, 2015Aug 10, 2015Oct 25, 2015Mar 14, 2016Apr 19, 2016Aug 16, 2016Oct 28, 2016Mar 27, 2017Apr 24, 2017Aug 17, 2017Oct 26, 2017Apr 27, 2018Aug 29, 2018Oct 25, 2018Feb 27, 2019Apr 26, 2019Aug 26, 2019Oct 24, 2019Feb 28, 2020Apr 28, 2020Aug 18, 2020Oct 27, 2020Apr 27, 2021Aug 25, 2021Oct 22, 2021Dec 31, 2021Apr 26, 2022Aug 26, 2022Oct 26, 2022Dec 31, 2022Apr 26, 2023Aug 30, 2023Oct 27, 2023Feb 23, 2024Apr 19, 2024Aug 23, 2024Oct 23, 2024Dec 31, 2024Apr 22, 2025Aug 20, 2025Oct 24, 2025Dec 31, 2025Apr 21, 2026Aug 20, 2026
EPS Estimate------------0.05-0.060.13-0.11---0.13--0.13------0.15-0.14---0.580.47-0.040.431.010.79-1.610.690.740.320.050.190.260.12-0.73-0.730.170.130.050.050.19
EPS Actual0.020.030.030.040.020.040.030.060.030.050.040.060.050.070.050.130.070.080.070.170.100.120.100.230.120.110.260.160.180.120.280.15-0.010.010.800.640.540.490.80-0.111.211.810.88-1.600.220.310.12-0.35-0.300.080.09-0.83-0.830.020.07-0.02-0.020.27
Surprise------------0.00%--16.67%0.00%--27.27%----7.69%---7.69%------0.00%--92.86%----15.52%70.21%-175.00%181.40%79.21%11.39%0.62%-68.12%-58.11%-62.50%-800.00%-257.89%-69.23%-25.00%-13.70%-13.70%-88.24%-44.00%-140.00%-140.00%42.11%
Timing-----------After-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours--After-hoursAfter-hours

Key Statistics & Ratios

Market Cap12.82B
Enterprise Value13.45B
Trailing P/E46.64
Forward P/E17.27
Price / Sales1.29
Price / Book2.03
EPS0.44
Book Value10.62
Revenue (TTM)9.93B
Gross Profit (TTM)2.91B
EBITDA1.11B
Profit Margin2.68%
Operating Margin12.31%
Return on Equity4.47%
Return on Assets3.64%
Shares Outstanding624.98M
Shares Float426.82M
Beta0.70
Dividend Yield1.71%
Dividend Rate0.35
Payout Ratio116.67%

Dividends

20261×
0.35Jun 25, 2026
20251×
0.25Jun 18, 2025
20242×
0.65Sep 20, 20240.06Jun 13, 2024
20231×
0.20May 31, 2023
20221×
0.14Jun 8, 2022
20211×
0.13Jun 24, 2021
20201×
0.13Jul 27, 2020
20191×
0.03Jun 27, 2019
20181×
0.03Jun 11, 2018
20171×
0.03Jun 8, 2017
20161×
0.06May 9, 2016
20151×
0.06Apr 29, 2015
20141×
0.05Jun 4, 2014
20131×
0.02May 31, 2013
20121×
0.02May 31, 2012

Stock Splits

  • May 9, 201618:10
  • Apr 29, 201513:10
  • Jun 4, 201417:10
  • May 31, 201313:10
  • May 31, 201218:10